SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006712
Filing Date
2021-05-10
Accepted
2021-05-10 17:02:26
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tgtx-20210331x10q.htm   iXBRL 10-Q 1562339
2 EX-31.1 tgtx-20210331xex31d1.htm EX-31.1 13666
3 EX-31.2 tgtx-20210331xex31d2.htm EX-31.2 13637
4 EX-32.1 tgtx-20210331xex32d1.htm EX-32.1 6679
5 EX-32.2 tgtx-20210331xex32d2.htm EX-32.2 6617
  Complete submission text file 0001558370-21-006712.txt   5784025

Data Files

Seq Description Document Type Size
6 EX-101.SCH tgtx-20210331.xsd EX-101.SCH 42648
7 EX-101.CAL tgtx-20210331_cal.xml EX-101.CAL 51899
8 EX-101.DEF tgtx-20210331_def.xml EX-101.DEF 148421
9 EX-101.LAB tgtx-20210331_lab.xml EX-101.LAB 403154
10 EX-101.PRE tgtx-20210331_pre.xml EX-101.PRE 281316
11 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20210331x10q_htm.xml XML 889661
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 21908201
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences